{
    "Trade/Device Name(s)": [
        "FORA G90 Perform Blood Glucose Monitoring System"
    ],
    "Submitter Information": "TaiDoc Technology Corporation",
    "510(k) Number": "K100405",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091898"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "June 22, 2010",
    "Summary Letter Received Date": "June 30, 2010",
    "Submission Date": "02/12/2010",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FORA G90 Perform Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Glucose oxidase"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for FORA G90 Perform Blood Glucose Monitoring System for quantitative measurement of glucose in capillary blood using electrochemical biosensor technology.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from finger and alternative sites; for use by healthcare professionals and people with diabetes at home to monitor diabetes control, not for diagnosis or use on neonates.",
    "fda_folder": "Clinical Chemistry"
}